# The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract

> **NCT06365762** · PHASE1,PHASE2 · COMPLETED · sponsor: **Livionex Inc.** · enrollment: 111 (actual)

## Conditions studied

- Age Related Cataracts

## Interventions

- **DRUG:** EDTA Ophthalmic Solution 2.6%
- **DRUG:** EDTA Ophthalmic Solution 1.3%
- **DRUG:** Saline Solution (Placebo)

## Key facts

- **NCT ID:** NCT06365762
- **Lead sponsor:** Livionex Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01-01
- **Primary completion:** 2006-12-31
- **Final completion:** 2007-04-30
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06365762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06365762, "The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06365762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*